Ashiq Mubarack

Stock Analyst at Citigroup

(0.28)

# 2,545

Out of 4,479 analysts

2

Total ratings

n/a

Success rate

-9.59%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$2.18	+266.97%	1	Dec 15, 2023
	MRSN Mersana Therapeutics	Upgrades: Buy	$1 → $5	$1.86	+168.82%	1	Dec 4, 2023

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $2.18

Upside: +266.97%

Mersana Therapeutics

Dec 4, 2023

Upgrades: Buy

Price Target: $1 → $5

Current: $1.86

Upside: +168.82%